Labcorp Receives FDA Approval for First Companion Diagnostic for Use With Pfizer's Newly Approved Gene Therapy to Treat Patients With Hemophilia B
Labcorp获得美国食品药品管理局的批准,可与辉瑞新批准的基因疗法一起用于治疗乙型血友病患者
Labcorp Receives FDA Approval for First Companion Diagnostic for Use With Pfizer's Newly Approved Gene Therapy to Treat Patients With Hemophilia B
Labcorp获得美国食品药品管理局的批准,可与辉瑞新批准的基因疗法一起用于治疗乙型血友病患者
使用浏览器的分享功能,分享给你的好友吧